Enhancer of zeste homologue 2 (EZH2) expression in synovial sarcomas as a promising indicator of prognosis. Biomol Biomed [Internet]. 2017 Nov. 20 [cited 2024 Apr. 29];17(4):302-8. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/1938